Therapixel will be showcasing MammoScreen™ at the virtual ECR 2021
Stop by our booth to learn more about our FDA-cleared and newly CE-marked AI for breast cancer screening
Therapixel receives the CE mark for its Artificial Intelligence-based software (AI) MammoScreen™
This cutting-edge technology assists radiologists in the interpretation of screening mammograms and allows them to diagnose breast cancer earlier and more accurately.
Therapixel and RAD-AID International Announce Breast Imaging AI Collaboration for Global Health
The collaboration donates and supports AI for making breast cancer screening more accessible and available in impoverished regions of the world
Scientific Publications
Performances of using Mammoscreen™️ have been demonstrated in a multiple scientific publications. We are currently working on many projects in both the US and Europe.
Therapixel participates in the Journées Francophones de Radiologie 2020
Experience the Award-winning MammoScreen™ at our virtual booth on the online platform JFR.plus
Therapixel is now ISO/IEC 27001 certified
Our information security management system is compliant with the world gold standard, ensuring a high level of cybersecurity.